In India, they approved the hope for coronavirus. The control study was performed, all patients recovered Curiosities

VAG8242fe_11_HEALTH_CORONAVIRUS_USA_0318_1N.JPG

Dill Indian councils have authorized the use of Itolizumab by the home-owned pharmaceutical company Biocon for the treatment of mild and external respiratory tract, including those caused by covive-19. Lkai will be able to sweat the sweat, which proved itself in clinical trials, according to Reuters.

A randomized control study showed that all Itolizumab-treated patients responded positively and recovered, Biocon said. In the control group, whose members were given a placebo, ie a drug without an insect, several people died as a result of covid-19.

Lkai and scientists are closely following the tests of this product, which could be one of the first cases of covid-19 disease, with which more than 561,000 people have died worldwide. Coronavir, which in some cases causes the disease, has infected 12.5 million people worldwide. India is the most affected country in the United States and Brazil, so far SARS-CoV-2 has been confirmed in 821,000 people, of which 22,000 have succumbed.

According to a recent British study, the corticosteroid dexamethasone has been shown to have an effect on drugs coronavirus dexamethasone, which is used, for example, as an adjunct to anti-cancer drugs, but also in sweat, disease and lung disease. Itolizumab approved in India is used, for example, in lb psoriasis.


Share on facebook
Facebook
Share on pinterest
Pinterest
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending